Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia
- PMID: 9531570
Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia
Abstract
Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARalpha fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocation and expression of the PLZF-RARalpha fusion protein. Both PML- and PLZF-RARalpha possess identical RAR sequences and inhibit ATRA-induced gene transcription as well as cell differentiation. We now show that the above-mentioned oncogenic fusion proteins interact with the nuclear receptor corepressor N-CoR and, in comparison with the wild-type RARalpha protein, their interactions display reduced sensitivities to ATRA. Although pharmacologic concentration of ATRA could still induce dissociation of N-CoR from PML-RARalpha, it had a very little effect on its association with the PLZF-RARalpha fusion protein. This ATRA-insensitive interaction between N-CoR and PLZF-RARalpha was mediated by the N-terminal PLZF moiety of the chimera. It appears that N-CoR/histone deacetylase corepressor complex interacts directly in an ATRA-insensitive manner with the BTB/POZ-domain of the wild-type PLZF protein and is required, at least in part, for its function as a transcriptional repressor. As the above-noted results predict, histone deacetylase inhibitors antagonize oncogenic activities of the PML-RARalpha fusion protein and partially relieve transcriptional repression by PLZF as well as inhibitory effect of PLZF-RARalpha on ATRA response. Taken together, our results demonstrate involvement of nuclear receptor corepressor/histone deacetylase complex in the molecular pathogenesis of APL and provide an explanation for differential sensitivities of PML- and PLZF-RARalpha-associated leukemias to ATRA.
Similar articles
-
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.Nature. 1998 Feb 19;391(6669):815-8. doi: 10.1038/35901. Nature. 1998. PMID: 9486655
-
Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.Hematol J. 2001;2(6):385-92. doi: 10.1038/sj.thj.6200138. Hematol J. 2001. PMID: 11920278
-
Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.J Biol Chem. 2003 Aug 15;278(33):30788-95. doi: 10.1074/jbc.M303309200. Epub 2003 Jun 5. J Biol Chem. 2003. PMID: 12794076
-
Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.Semin Hematol. 2001 Jan;38(1):37-41. doi: 10.1016/s0037-1963(01)90004-6. Semin Hematol. 2001. PMID: 11172538 Review.
-
Acute promyelocytic leukemia: from clinic to molecular biology.Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
Cited by
-
The epigenetic regulator PLZF represses L1 retrotransposition in germ and progenitor cells.EMBO J. 2013 Jul 3;32(13):1941-52. doi: 10.1038/emboj.2013.118. Epub 2013 May 31. EMBO J. 2013. PMID: 23727884 Free PMC article.
-
8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3495-500. doi: 10.1073/pnas.1222863110. Epub 2013 Feb 4. Proc Natl Acad Sci U S A. 2013. PMID: 23382200 Free PMC article.
-
Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene.Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11422-7. doi: 10.1073/pnas.96.20.11422. Proc Natl Acad Sci U S A. 1999. PMID: 10500192 Free PMC article.
-
Oligomerization of ETO is obligatory for corepressor interaction.Mol Cell Biol. 2001 Jan;21(1):156-63. doi: 10.1128/MCB.21.1.156-163.2001. Mol Cell Biol. 2001. PMID: 11113190 Free PMC article.
-
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.EMBO J. 2001 Dec 17;20(24):6969-78. doi: 10.1093/emboj/20.24.6969. EMBO J. 2001. PMID: 11742974 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials